In a randomized phase 2 trial (60 postmenopausal women), D+Q had no overall effect on bone, with a modest benefit in women with a high senescent-cell burden.
Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).